C&D Emerging Industry Equity Investment

Activity from announced rounds

All recorded activity
Rounds participated in
4
Confirmed lead rounds
1
2 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$211.7M
3 disclosed · full round size, not this investor’s share

By stage

Series A3
Series C+1

By primary sector

AI1
Biotech1
Healthtech1
Robotics1

By country

China3
Singapore1

Rounds

4 in all activity
Nanochap

Develops retinal and cortical brain-computer interfaces that use electrical stimulation to create artificial visual perception.

CN¥500MSeries C+
Participant
Vivacta Biotechnology

Develops in vivo CAR-T cell therapies for cancer and autoimmune diseases

$50MSeries A+
Role not disclosed
ShengShu Technology

Develops multimodal foundation models for video generation and AI productivity

CN¥600MSeries A
Role not disclosed
WEIBUILD

Shanghai-based maker of robots for wall plastering, spraying, site modelling and automated rebar processing.

UndisclosedSeries A++
Lead